(19)
(11) EP 1 198 463 A2

(12)

(88) Date of publication A3:
08.03.2001

(43) Date of publication:
24.04.2002 Bulletin 2002/17

(21) Application number: 00942181.9

(22) Date of filing: 14.06.2000
(51) International Patent Classification (IPC)7C07D 405/12, C07D 211/58, C07D 409/12, A61K 31/4468, A61K 31/453, A61K 31/4535, A61P 25/28
(86) International application number:
PCT/GB0002/315
(87) International publication number:
WO 0078/751 (28.12.2000 Gazette 2000/52)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 17.06.1999 GB 9914022

(71) Applicant: AstraZeneca UK Limited
London W1Y 6LN (GB)

(72) Inventors:
  • WARAWA, Edward, John
    Wilmington, DE 19850-5437 (US)
  • MCLAREN, Charles, David
    Wilmington, DE 19850-5437 (US)
  • SIMON-BIERENBAUM, Richard, Elliot
    Wilmington, DE 19850-5437 (US)

(74) Representative: Wahlström, Stig Christer Gunnar 
Astra ABIntellectual Property, Patents
S-151 85 Södertälje
S-151 85 Södertälje (SE)

   


(54) COMPOUNDS FOR USE IN TREATMENT OF NEUROLOGICAL DISORDERS